BioSpace News Archive

Business

Daré Bioscience to Host Third Quarter 2022 Financial Results and Company Update Conference Call and Webcast on November 10, 2022

Daré Bioscience, Inc. announced that it will host a conference call and live webcast at 4:30 p.m. Eastern Time on Thursday, November 10, 2022, to review its financial results for the quarter ended September 30, 2022 and to provide a Company update.

November 3, 2022
·
3 min read
Business

Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 10, 2022

Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue, complex tissue systems, and organs at commercial scale, will release its financial results for the third quarter ended September 30, 2022, on Thursday, November 10, 2022.

November 3, 2022
·
2 min read
Business

IO Biotech Announces New Clinical Collaboration with Merck to Evaluate Neoadjuvant and Adjuvant IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) in a Phase 2, Multi-cohort Trial in Patients with Resectable Tumors

IO Biotech announced that it has entered into a fourth clinical trial collaboration and supply agreement with Merck & Co., Inc., Rahway, NJ, USA, through a subsidiary.

November 3, 2022
·
4 min read
Genetown

Galecto to Participate in Jefferies 2022 London Healthcare Conference

Galecto, Inc. announced that management will present at the upcoming Jefferies London Healthcare Conference taking place on November 15-17, 2022.

November 3, 2022
·
1 min read
Business

Madrigal Pharmaceuticals Provides an Overview of Upcoming Resmetirom Data Presentations and Reports 2022 Third Quarter Financial Results

Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis, provides an overview of upcoming resmetirom Phase 3 data presentations and reports third quarter 2022 financial results.

November 3, 2022
·
17 min read
Business

Protara Therapeutics Announces Third Quarter 2022 Financial Results and Business Overview

Protara Therapeutics, Inc., a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, announced financial results for the third quarter ended September 30, 2022 and provided a business update.

November 3, 2022
·
11 min read
Biotech Beach

Reneo Pharmaceuticals to Participate at Upcoming November 2022 Investor Conferences

Reneo Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, announced that the company’s management team will participate at three upcoming healthcare conferences.

November 3, 2022
·
1 min read
Business

Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022

Iterum Therapeutics plc announced that the Company will release its third quarter 2022 financial results before the open of the U.S. financial markets on Thursday, November 10, 2022.

November 3, 2022
·
1 min read
Business

CinCor Reports Third Quarter 2022 Financial Results and Provides Corporate Update

CinCor Pharma, Inc. announced financial results for the third quarter ended September 30, 2022 and provided a corporate update.

November 3, 2022
·
13 min read
Biotech Beach

New Report from GoodRx Shows Positive Impact of Giving Pharmacists the Power to Prescribe

GoodRx (NASDAQ: GDRX), a leading consumer-focused digital healthcare platform, today released a new report that indicates that policies that expand pharmacists’ prescribing and dispensing authority greatly improve access to critical medications.

November 3, 2022
·
3 min read